Search - tctmd.com

Displaying 341 - 360 of 612

Sort: Relevancy | Date

Presentation TVT 2019

Highlights From the PARTNER 3 Low-Risk Trial

Presenter: Michael Mack

June 13, 2019

Presentation TVT 2019

Highlights From the CoreValve Low-Risk Trial

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

The PARTNER 3 Low-Risk Randomized Trial

Presenter: Susheel Kodali

June 13, 2019

Presentation TVT 2019

The Evolut Low-Risk Randomized Trial

Presenter: Steven Yakubov

June 13, 2019

Presentation TVT 2019

Meta-Analysis of 1-Year Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis

Presenter: Aaqib H Malik

June 13, 2019

News Daily News

Potential Warning Signs Seen for NOAC Use After TAVR

Todd Neale

June 12, 2019

Presentation TVT 2019

Low-Risk Approval: Who Isn’t a Candidate for TAVR?

Presenter: Tsuyoshi Kaneko

June 12, 2019

News Daily News

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Michael O'Riordan

June 12, 2019

News Daily News

CAD’s Genetic Basis Strongly Overlaps With Other Vascular Conditions and Risk Factors

Caitlin E. Cox

June 12, 2019

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

News Conference News EuroPCR 2019

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

L.A. McKeown

June 07, 2019

News Conference News EAS 2019

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Michael O'Riordan

June 07, 2019

News Conference News EuroPCR 2019

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

Caitlin E. Cox

June 07, 2019

News Conference News EuroPCR 2019

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

L.A. McKeown

June 06, 2019

News Daily News

Mortality Lower When STEMI Patients Sent to the ICU, but Why?

Todd Neale

June 06, 2019

News Conference News EAS 2019

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

Michael O'Riordan

June 05, 2019

News Conference News EuroPCR 2019

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

Caitlin E. Cox

June 05, 2019

News Conference News EAS 2019

Inclisiran Safe and Effective in Patients With Impaired Renal Function: ORION

Michael O'Riordan

June 04, 2019

News Conference News SCAI 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

Yael L. Maxwell

June 04, 2019

Advertisement

Highlights From the PARTNER 3 Low-Risk Trial

Highlights From the CoreValve Low-Risk Trial

The PARTNER 3 Low-Risk Randomized Trial

The Evolut Low-Risk Randomized Trial

Meta-Analysis of 1-Year Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis

Potential Warning Signs Seen for NOAC Use After TAVR

Low-Risk Approval: Who Isn’t a Candidate for TAVR?

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

CAD’s Genetic Basis Strongly Overlaps With Other Vascular Conditions and Risk Factors

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

Mortality Lower When STEMI Patients Sent to the ICU, but Why?

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

Inclisiran Safe and Effective in Patients With Impaired Renal Function: ORION

TAVR Operators: Can One Do It All or Are Two Still Justified?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content